ClinicalTrials.Veeva

Menu

B2RAD Translational Medicine Study

S

Sohail Rao

Status

Unknown

Conditions

Specimens Are to be Collected From Subjects Who Are Having or Have Had a Fluid or Tissue Removed, a Biopsy or a Blood or Bone Marrow Draw

Treatments

Other: Specimen Collection

Study type

Observational

Funder types

Other

Identifiers

NCT05292430
1551551

Details and patient eligibility

About

Recent advances in understanding the molecular and cellular pathology of many diseases have resulted in direct benefit to today's patients. The translational research studies that have led to these advances relied on an integrated model of clinical and non-clinical laboratory investigations based on the analysis of human biospecimens that lead directly to drug discovery, drug validation, novel detection assays, and prognostic marker discovery. Translational research provides a unique mechanism to address questions specific to particular tumor or other disease types, biological modifiers and/or mechanisms of action that are essential for the advancement of healthcare. Specimens are to be collected from subjects who are having or have had a surgical or medical procedure (such as fluid or tissue removed, a biopsy or a blood or bone marrow draw). Any subject in which the primary diagnosis of disease was made within the DHR Health System and Any subject choosing to give consent for participation will be included

Enrollment

1,000 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Any subject choosing to give consent for participation will be included.
  2. Any subject in which the primary diagnosis of cancer was made at the DHR Health System.

Exclusion criteria

  1. Any subject deemed unable to provide legally effective consent.
  2. Any pediatric subject where the subject does not freely give his or her assent or where his or her parent/guardian does not give consent.

Trial design

1,000 participants in 1 patient group

Biobank
Description:
Specimens are to be collected from subjects who are having or have had a surgical or medical procedure (such as fluid or tissue removed, a biopsy or a blood or bone marrow draw). Any subject in which the primary diagnosis of disease was made within the DHR Health System and Any subject choosing to give consent for participation will be included.
Treatment:
Other: Specimen Collection

Trial contacts and locations

2

Loading...

Central trial contact

Sohail Rao, MD; Monica Betancourt-Garcia, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems